Max-interacting proteins and related molecules and methods
AssigneeThe General Hospital Corporation
InventorsRoger Brent, Antonis S. Zervos
Life of this patent
Estimating the term…
Abstract
Disclosed are substatially pure preparations of Max-Interacting (Mxi) polypeptides, DNA encoding such polypeptides, antibodies recognizing such polypeptides, and diagnostic and therapeutic methods utilizing such polypeptides.
Claims6
A substantially pure polypeptide comprising the sequence of SEQ ID NO:
- 2.
An Mxi polypeptide produced by expression of a purified DNA comprising a sequence encoding the amino acid sequence of SEQ ID NO:
- 2.
A substantially pure polypeptide comprising amino acids 91-112 of the Mxi1 sequence of SEQ ID NO:
- 2.
A substantially pure polypeptide comprising amino acids 68-112 of the Mxi1 sequence of SEQ ID NO:
- 2.
A substantially pure polypeptide comprising the sequence of SEQ ID NO:
- 4.
An Mxi polypeptide produced by expression of a purified DNA comprising a sequence encoding the amino acid sequence of SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.